EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 1 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,845,650 | -6.2% | 776,797 | -7.9% | 0.34% | +39.1% |
| Q3 2022 | $8,362,000 | +68.7% | 843,223 | +66.5% | 0.24% | +84.1% |
| Q2 2022 | $4,958,000 | +0.2% | 506,479 | 0.0% | 0.13% | +3.9% |
| Q1 2022 | $4,946,000 | +0.7% | 506,479 | 0.0% | 0.13% | -3.8% |
| Q4 2021 | $4,913,000 | +1101.2% | 506,479 | +1103.6% | 0.13% | +1000.0% |
| Q3 2021 | $409,000 | 0.0% | 42,079 | 0.0% | 0.01% | -7.7% |
| Q2 2021 | $409,000 | – | 42,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |